Aphria Inc Equity-NMS: APHA

Healthcare

Drug Manufacturers - Specialty & Generic

Buy/Sell an entire stock
or a fraction.

Vested

Already an existing customer?

New User?

Open Your Free Demat Account And Start Trading Seamlessly

Loading, Please wait...

Error in Fetching Data, Please retry later.

No data available.

Previous close :

$15.45

5Y :

-6.43%

What is the share price of Aphria Inc today?

Aphria Inc (APHA) share price as of February 6, 2026, is $15.375. If you are investing from India, you can always check the valuation in the INR before investing.

Can Indian Investors purchase shares of Aphria Inc?

Yes, Indian Investors can invest in the Aphria Inc (APHA) Share by opening an international trading account with Angel One.

How can I purchase Aphria Inc shares in India?

Purchasing Aphria Inc (APHA) share from India can be done by:

Directly: By opening an international trading account with Angel One. The process would include KYC verification.
The account activation takes a few minutes to a few hours, after which you can start buying Aphria Inc (APHA) by making deposits in US dollars.
Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.

Can I buy Fractional shares of Aphria Inc?

Yes, you can purchase fractional shares of Aphria Inc (APHA) or any other US company shares in Angel One for any dollar amount.

What is the market capitalization value of Aphria Inc?

The market capitalization of Aphria Inc on February 6, 2026, is $0.

In which sector Aphria Inc belongs?

Aphria Inc operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.

What documents are required to invest in Aphria Inc stocks?

In order to invest in Aphria Inc (APHA) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.)

From start to end, the process is digital and can be seamless.

Aphria Inc is a Canada-based company, which is engaged in producing and selling cannabis. Through its subsidiary Broken Coast Cannabis Ltd and Aphria One facility, the Company produces and sells medical and recreational cannabis. Aphria One serves as the basis, on which the Company develops techniques in cultivation, extraction and processing cannabis. The purpose-built, indoor cannabis production facility of Broken Coast Cannabis Ltd provides the Company with B.C. Bud cannabis brand. Broken Coast cannabis is grown on the shores of the Salish Sea in small batches by choice, using single-strain rooms. Through its subsidiary and international organization Aphria International, the Company is focused on building a global cannabis brand. Solei Sungrown Cannabis is the Company's first adult-use brand. The Company has presence in more than 10 countries across 5 continents.